Literature DB >> 14751129

What is the clinical value of adding tamoxifen to progestins in the treatment [correction for treament] of advanced or recurrent endometrial cancer?

Thomas J Herzog.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751129     DOI: 10.1016/j.ygyno.2003.11.014

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  5 in total

1.  Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.

Authors:  Richard J Zaino; William E Brady; William Todd; Kimberly Leslie; Edgar G Fischer; Neil S Horowitz; Robert S Mannel; Joan L Walker; Marina Ivanovic; Linda R Duska
Journal:  Int J Gynecol Pathol       Date:  2014-11       Impact factor: 2.762

Review 2.  The Use of Targeted Agents in the Treatment of Gynecologic Cancers.

Authors:  Shaina F Bruce; Matthew A Powell
Journal:  Curr Treat Options Oncol       Date:  2022-02-15

Review 3.  Molecular targeted therapy in gynaecologic malignancies: primer for radiologists.

Authors:  Chong Hyun Suh; Sree H Tirumani; Abhishek Keraliya; Kyung Won Kim; Nikhil H Ramaiya; Atul B Shinagare
Journal:  Br J Radiol       Date:  2016-07-12       Impact factor: 3.039

4.  Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer.

Authors:  Elisa Rossini; Mariangela Tamburello; Andrea Abate; Silvia Beretta; Martina Fragni; Manuela Cominelli; Deborah Cosentini; Constanze Hantel; Federica Bono; Salvatore Grisanti; Pietro Luigi Poliani; Guido A M Tiberio; Maurizio Memo; Sandra Sigala; Alfredo Berruti
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-26       Impact factor: 5.555

5.  Contemporary clinical management of endometrial cancer.

Authors:  Helen E Dinkelspiel; Jason D Wright; Sharyn N Lewin; Thomas J Herzog
Journal:  Obstet Gynecol Int       Date:  2013-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.